Casdin-Capital

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
44
Total Value
1223806401
Accession Number
0000919574-25-003248
Form Type
13F-HR
Manager Name
Casdin-Capital
Data Enrichment
95% identified
42 identified2 unidentified

Holdings

44 positions • $1.2B total value
Manager:
Search and click to pin securities to the top
Page 2 of 3
578784100
Shares:946.4K
Value:$10.4M
% of Portfolio:0.9% ($10.4M/$1.2B)
2seventy bio, Inc.
Shares:2.0M
Value:$9.9M
% of Portfolio:0.8% ($9.9M/$1.2B)
VERACYTE, INC.
Shares:276.3K
Value:$8.2M
% of Portfolio:0.7% ($8.2M/$1.2B)
GE HealthCare Technologies Inc.
Shares:100.0K
Value:$8.1M
% of Portfolio:0.7% ($8.1M/$1.2B)
Syndax Pharmaceuticals Inc
Shares:635.0K
Value:$7.8M
% of Portfolio:0.6% ($7.8M/$1.2B)
AGIOS PHARMACEUTICALS, INC.
Shares:250.0K
Value:$7.3M
% of Portfolio:0.6% ($7.3M/$1.2B)
Moderna, Inc.
Shares:225.0K
Value:$6.4M
% of Portfolio:0.5% ($6.4M/$1.2B)
Hims & Hers Health, Inc.
Shares:200.0K
Value:$5.9M
% of Portfolio:0.5% ($5.9M/$1.2B)
Tenaya Therapeutics, Inc.
Shares:6.7M
Value:$3.8M
% of Portfolio:0.3% ($3.8M/$1.2B)
Verastem, Inc.
Shares:600.0K
Value:$3.6M
% of Portfolio:0.3% ($3.6M/$1.2B)
Septerna, Inc.
Shares:553.3K
Value:$3.2M
% of Portfolio:0.3% ($3.2M/$1.2B)
Solid Biosciences Inc.
Shares:775.0K
Value:$2.9M
% of Portfolio:0.2% ($2.9M/$1.2B)
Absci Corp
Shares:973.3K
Value:$2.4M
% of Portfolio:0.2% ($2.4M/$1.2B)
Teladoc Health, Inc.
Shares:300.0K
Value:$2.4M
% of Portfolio:0.2% ($2.4M/$1.2B)
Century Therapeutics, Inc.
Shares:3.2M
Value:$1.5M
% of Portfolio:0.1% ($1.5M/$1.2B)
Dyne Therapeutics, Inc.
Shares:100.0K
Value:$1.0M
% of Portfolio:0.1% ($1.0M/$1.2B)
Contineum Therapeutics, Inc.
Shares:148.3K
Value:$1.0M
% of Portfolio:0.1% ($1.0M/$1.2B)
RECURSION PHARMACEUTICALS, INC.
Shares:165.3K
Value:$874.6K
% of Portfolio:0.1% ($874.6K/$1.2B)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Shares:723.8K
Value:$854.0K
% of Portfolio:0.1% ($854.0K/$1.2B)
Prime Medicine, Inc.
Shares:367.2K
Value:$730.7K
% of Portfolio:0.1% ($730.7K/$1.2B)